Failure Pattern of Oligometastatic EGFR-Mutant Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitors: Implication of Upfront Stereotactic Body Radiation Therapy

Kinase Inhibitors ◽

Stereotactic Body Radiation Therapy ◽

Small Cell ◽

Small Cell Lung ◽

First-line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-mutant Metastatic Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.1866 ◽

2018 ◽

Vol 102 (3) ◽

pp. e693

Author(s):

X. Lu ◽

J. Wang ◽

C. Wang ◽

N. Bi ◽

Z. Zhou ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Local Therapy ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

P3.02b-035 Cell Free Tumor DNA to Monitor Response to Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1702 ◽

2017 ◽

Vol 12 (1) ◽

pp. S1208

Author(s):

Paola Ulivi ◽

Elisa Chiadini ◽

Giorgia Marisi ◽

Vienna Ludovini ◽

Nicoletta De Luigi ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Mutant ◽

Tumor Dna

Predictors of outcome for EGFR-mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors

Lung Cancer Management ◽

10.2217/lmt.12.57 ◽

2013 ◽

Vol 2 (2) ◽

pp. 89-92

Author(s):

Sara Pilotto ◽

Emilio Bria

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Predictors Of Outcome ◽

Small Cell Lung ◽

First Line ◽

Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.09.02 ◽

2019 ◽

Vol 8 (S4) ◽

pp. S387-S390

Author(s):

Jacek Jassem

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer

International Journal of Biological Sciences ◽

10.7150/ijbs.57964 ◽

2021 ◽

Vol 17 (7) ◽

pp. 1671-1681

Author(s):

Yuan Luo ◽

Shijing Ma ◽

Yingming Sun ◽

Shan Peng ◽

Zihang Zeng ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

Oncotarget ◽

10.18632/oncotarget.19411 ◽

2017 ◽

Vol 8 (65) ◽

pp. 108522-108533 ◽

Cited By ~ 4

Author(s):

Jinjing Xia ◽

Hao Bai ◽

Bo Yan ◽

Rong Li ◽

Minhua Shao ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Bh3 Domain ◽

Feasibility of rebiopsy and sequential treatment of EGFR tyrosine kinase inhibitors in real world patients with EGFR mutant non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz437.018 ◽

2019 ◽

Vol 30 ◽

pp. ix166

Author(s):

H. Ahn ◽

Y. Kim ◽

E.Y. Kim ◽

K.W. Kim ◽

K.H. Sung ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Real World ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough?

Journal of Thoracic Disease ◽

10.21037/jtd-20-1817 ◽

2020 ◽

Vol 12 (9) ◽

pp. 5042-5045

Author(s):

Christopher Lemmon ◽

Nathan A. Pennell

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.68 ◽

2019 ◽

Vol 11 (10) ◽

pp. 4092-4095

Author(s):

Fernando Franco ◽

Mariano Provencio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Neoadjuvant Treatment ◽

Small Cell ◽

Small Cell Lung

Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non–small-cell Lung Cancer Treated in the Real-World

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.01.019 ◽

2021 ◽

Author(s):

Bernardo H.L. Goulart ◽

Shasank Chennupati ◽

Catherine R. Fedorenko ◽

Scott D. Ramsey

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Alk Positive